1.5 Abstract in rivista

1.5 Abstract in rivista: [1410] Home page tipologia

Sfoglia

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 201 a 220 di 1.410

Abstract P5-15-07: First and further line choices of treatment for HER2-VE metastatic breast cancer (MBC) according to adjuvant treatment and biological subtype. Preliminary results of the observational “GIM-13 – AMBRA” Italian study

2017-01-01 Mustacchi, G; Cazzaniga, Me; Biganzoli, L; De Laurentiis, M; Del Mastro, L; De Placido, S; Donadio, M; Garrone, O; Giordano, M; Latini, L; Livi, L; Marchetti, P; Michelotti, A; Montemurro, F; Natoli, C; Pronzato, P; Riccardi, F; Turletti, A

ABIRATERONE ACETATE FOR TREATMENT OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER IN CHEMOTHERAPY-NAIVE PATIENTS: AN ITALIAN MULTICENTER 'REAL-LIFE' 1-YEAR STUDY

2017-01-01 Cindolo, Luca; Natoli, Clara; De Nunzio, C; DE TURSI, Michele; Valeriani, M; Giacinti, S; Micali, S; Rizzo, M; Bianchi, G; Martoran, E; Scarcia, M; Ludovico, Gm; Bove, P; Laudisi, A; Selvaggio, O; Carrieri, G; Bada, M; Castellan, P; Boccasile, S; Ditonn, P; Chiodini, P; Verze, P; Mirone, V; Schips, Luigi

CARAMEL study: Clinical prognostic biomarkers for ipilimumab-related outcome in metastatic melanoma patients

2016-01-01 Orgiano, Laura; Bruder, Francesca; Madeddu, Clelia; Marconcini, Riccardo; Gambale, Elisabetta; Galizia, Eva; Stucci, Stefania; Spagnolo, Francesco; Di Guardo, Lorenza; Carla, Loi; Pani, Fabiana; Massa, Daniela; Massa, Elena; Astara, Giorgio; Del Vecchio, Michele; Silvestris, Francesco; Natoli, Clara; Falcone, Alfredo; Queirolo, Paola; Scartozzi, Mario

MiR-181b in Chronic Lymphocytic Leukemia B Cells Is Regulated By Cellular Interaction with CD4+ T Cells and Increases the CTL Toxicity Versus the Leukemic Clone

2015-01-01 DI MARCO, AMERIGO MIRCO; Veschi, Serena; Visone, Rosa; Giuseppe, Leone; Lanuti, Paola; Pagotto, Sara; Pepe, Felice; Stefania, Pacillo; Curcio, Claudia; Marchisio, Marco; Miscia, Sebastiano; Idanna, Innocenti; Francesco, Autore; Barbara, Vannata; DI GIOACCHINO, Mario; MARIANI COSTANTINI, Renato; Luca, Laurenti; Veronese, Angelo

Impact of occupational stress in italian offshore oil installation workers and cytokines homeostasis

2018-01-01 Di Giampaolo, L; Costantini, E; D’Angelo, C; Frassanito, F; Di Gioacchino, M; Di Nicola, M; Reale, M

Beekeeper allergy risk and work suitability

2018-01-01 Di Gioacchino, M; Di Giampaolo, L; Petrarca, C

Tio2and tio2-mesoporous silica nanoparticle toxicity evaluated on primary human peripheral blood mono/lymphocytes

2018-01-01 Petrarca, C; Clemente, E; Zaccariello, G; Sabbioni, E; Di Gioacchino, M

Treatment (T) of metastatic colorectal cancer (mCRC) patients (pts)≥ 75 years (y) old in clinical practice: A multicenter analysis.

2014-01-01 Grande, Roberta; Garufi, Carlo; Pavese, Ida; Ciancola, Fabrizio; Gemma, Donatello; Pellegrino, Arianna; Di Lauro, Luigi; Cors, Domenico C.; Signorelli, Diego; Sperduti, Isabella; Cortese, Giada; Risi, Emanuela; Moran, Federica; Sergi, Domenico; Signorelli, Carlo; Natoli, Clara; Ruggeri, Enzo; Zampa, Germano; Russano, Marco; Gamucci, Teresa

Relationship and predictive role of the dual expression of FGFR and IL8 in metastatic renal cell carcinoma (mRCC)

2015-01-01 Mosillo, C; Iacovelli, R; DE TURSI, Michele; Ciardi, A; Carella, C; Natoli, Clara; Naso, G; Corstesi, E

Fulvestrant (FUL) 500 milligrams as endocrine therapy (ET) for hormone sensitive advanced breast cancer patients (pts). The Ful500 prospective observational trial

2016-01-01 Moscetti, L.; Fabbri, M. A.; Vici, P.; Natoli, Clara; Gamucci, T.; Sperduti, I.; Pizzuti, L.; Iezzi, Laura; Iattoni, E.; Roma, C. L.; Vaccaro, A.; D'Auria, G.; Ruggeri, M. Mauri E. M.

Triple positive early breast cancer in the pre- and post Trastuzumab eras: a subgroup analysis of a multicenter retrospective study.

2014-01-01 Pizzuti, L; Natoli, Clara; Gamucci, T; Sergi, D; Di Lauro, L; Moscetti, L; Mentuccia, L; Vaccaro, A.; Trenta, P; Seminara, P; D'Onofrio, L; Rapposelli, ILARIO GIOVANNI; Iezzi, L; Sini, V; Barba, M; Maugeri Sacca, M; Sperduti, I; Marchetti, P; Vici, P

Predictive factors of response to neoadjuvant chemotherapy (NAT) in triple negative breast (TNBC) cancer patients: A restrospective multicenter observational study.

2017-01-01 Teresa, Gamucci; Lucia, Mentuccia; Patrizia, Vici; Iezzi, Laura; Isabella, Sperduti; Antonio, Astone; Paolo, Marchetti; Laura, Pizzuti; Andrea, Michelotti; Valentina, Sini; Alessandra, Cassano; Fabrizio, Ciancola; Moscetti, Luca I.; Silvia, Quadrini; Elisabetta, Landucci; Emanuela, Magnolfi; Domenico, Sergi; Natoli, Clara

L’UTILIZZO DEGLI ANTICORPI MONOCLONALI NELLA TERAPIA PER IL MCRC. L’ESPERIENZA DI REAL-LIFE IN UNA ASL ABRUZZESE

2017-01-01 Petragnani, N.; Simiele, F.; Antonelli, D.; Zappacosta, I.; Rignanese, L.; Ciampoli, R.; Matera, C.; Laudadio, L.; Natoli, C.; Di Fabio, C.

Impact of BMI on clinical outcome in advanced cancer patients treated with anti‑PD‑1 Immune checkpoint inhibitors: a preliminary analysis

2019-01-01 Cortellini, Alessio; DE TURSI, Michele; Tinari, Nicola; Grassadonia, Antonino; Parisi, Alessandro; Iezzi, Laura; Di Marino, Pietro; D’Ostilio, Nicola; Brocco, Davide; Bersanelli, Melissa; Peri, Marta; Cannita, Katia; Ficorella, Corrado; Natoli, Clara

Fulvestrant (FUL) as first-line therapy in HR+ve, HER2-ve advanced breast cancer (ABC) patients (pts): when clinical practice comes earlier than clinical trials. Results from the GIM-13 AMBRA study

2017-01-01 Pronzato, P; Mustacch, G; F Riccard, I; A Turletti, I; Michelotti, A; Natoli, C; Livi, L; Del Mastro, L; Donadio, M; Garrone, O; Giordano, M; De Laurentiis, M; Marchett, P; F Montemurro, I; Romagnoli, E; De Placido, S; Biganzoli, L; Cazzaniga, M

Trastuzumab Emtansine (T-DM1) in Patients (pts) With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (MBC): results From a Multicenter Retrospective Analysis

2016-01-01 Moscetti, L.; Fabbri, M. A.; Vici, P.; Natoli, Clara; Gamucc, T.; Sperduti, i I.; Pizzuti, L.; Iezzi, Laura; Iatton, E.; Roma, i C. L.; Vaccaro, A.; D'Auria, G.; Ruggeri, M. Mauri E. M.

Choices of first-line therapy in her2-ve advanced breast cancer (abc) patients (pts). prelimary results of the gim-13-ambra study

2016-01-01 Cazzaniga, Me; Mustacchi, G; Giordano, M; Garrone, O; Donadio, M; Del Mastro, L; Livi, L; Natoli, Clara; Michelotti, A; Turletti, A; Riccardi, F; Paolo, P; De Placido, S; De Laurentiis, M; Marchetti, P; Montemurro, F

Safety analysis, correlation with response and previous treatments of the association of everolimus (EVE) and exemestane (EXE) in 181 metastatic breast cancer patients (MBC)

2015-01-01 Moscetti, L; Vici, P; Sperduti, I; Fabbri, Ma; Natoli, Clara; Mancini, Ml; Sini, V; D'Onofrio, L; Pizzuti, L; Vaccaro, A; Magnolfi, E; Magri, V; Trenta, P; Ramponi, S; Roma, C; Ruggeri, Em

HER2-POSITIVE EARLY BREAST CANCER IN THE PRE-TRASTUZUMAB AND TRASTUZUMAB ERAS: A TRIPLE POSITIVE SUBGROUP ANALYSIS OF A MULTICENTER RETROSPECTIVE STUDY

2014-01-01 Pizzuti, Laura; Natoli, Clara; Gamucci, Teresa; Di Lauro, D. Sergi L.; Moscetti, Luca; Mentuccia, Lucia; Vaccaro, Angela; Trenta, P.; Seminara, Patrizia; Rapposelli, I. G.; Sini, V.; Santini, Daniele; Sperduti, Isabella; Marchetti, Paolo; Vici, Patrizia

LGALS3BP, A TUMOR-ASSOCIATED ANTIGEN, UPREGULATES VEGF IN HUMAN BREAST CANCER: POSSIBLE IMPLICATIONS IN ANGIOGENESIS

2008-01-01 Cumashi, Albana; Tinari, Nicola; Piccolo, Enza; Rossi, Cosmo; Lattanzio, Rossano; D'Incecco, Arnlida; Grassadonia, Antonino; D'Egidio, Maurizia; Serneraro, Daniela; Piantelli, Mauro; Natoli, Clara; Iacobelli, Stefano

Titolo	Data di pubblicazione	Autore(i)
Abstract P5-15-07: First and further line choices of treatment for HER2-VE metastatic breast cancer (MBC) according to adjuvant treatment and biological subtype. Preliminary results of the observational “GIM-13 – AMBRA” Italian study	2017	Mustacchi, G; Cazzaniga, Me; Biganzoli, L; De Laurentiis, M; Del Mastro, L; De Placido, S; Donadio, M; Garrone, O; Giordano, M; Latini, L; Livi, L; Marchetti, P; Michelotti, A; Montemurro, F; Natoli, C; Pronzato, P; Riccardi, F; Turletti, A
ABIRATERONE ACETATE FOR TREATMENT OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER IN CHEMOTHERAPY-NAIVE PATIENTS: AN ITALIAN MULTICENTER 'REAL-LIFE' 1-YEAR STUDY	2017	Cindolo, Luca; Natoli, Clara; De Nunzio, C; DE TURSI, Michele; Valeriani, M; Giacinti, S; Micali, S; Rizzo, M; Bianchi, G; Martoran, E; Scarcia, M; Ludovico, Gm; Bove, P; Laudisi, A; Selvaggio, O; Carrieri, G; Bada, M; Castellan, P; Boccasile, S; Ditonn, P; Chiodini, P; Verze, P; Mirone, V; Schips, Luigi
CARAMEL study: Clinical prognostic biomarkers for ipilimumab-related outcome in metastatic melanoma patients	2016	Orgiano, Laura; Bruder, Francesca; Madeddu, Clelia; Marconcini, Riccardo; Gambale, Elisabetta; Galizia, Eva; Stucci, Stefania; Spagnolo, Francesco; Di Guardo, Lorenza; Carla, Loi; Pani, Fabiana; Massa, Daniela; Massa, Elena; Astara, Giorgio; Del Vecchio, Michele; Silvestris, Francesco; Natoli, Clara; Falcone, Alfredo; Queirolo, Paola; Scartozzi, Mario
MiR-181b in Chronic Lymphocytic Leukemia B Cells Is Regulated By Cellular Interaction with CD4+ T Cells and Increases the CTL Toxicity Versus the Leukemic Clone	2015	DI MARCO, AMERIGO MIRCO; Veschi, Serena; Visone, Rosa; Giuseppe, Leone; Lanuti, Paola; Pagotto, Sara; Pepe, Felice; Stefania, Pacillo; Curcio, Claudia; Marchisio, Marco; Miscia, Sebastiano; Idanna, Innocenti; Francesco, Autore; Barbara, Vannata; DI GIOACCHINO, Mario; MARIANI COSTANTINI, Renato; Luca, Laurenti; Veronese, Angelo
Impact of occupational stress in italian offshore oil installation workers and cytokines homeostasis	2018	Di Giampaolo, L; Costantini, E; D’Angelo, C; Frassanito, F; Di Gioacchino, M; Di Nicola, M; Reale, M
Beekeeper allergy risk and work suitability	2018	Di Gioacchino, M; Di Giampaolo, L; Petrarca, C
Tio2and tio2-mesoporous silica nanoparticle toxicity evaluated on primary human peripheral blood mono/lymphocytes	2018	Petrarca, C; Clemente, E; Zaccariello, G; Sabbioni, E; Di Gioacchino, M
Treatment (T) of metastatic colorectal cancer (mCRC) patients (pts)≥ 75 years (y) old in clinical practice: A multicenter analysis.	2014	Grande, Roberta; Garufi, Carlo; Pavese, Ida; Ciancola, Fabrizio; Gemma, Donatello; Pellegrino, Arianna; Di Lauro, Luigi; Cors, Domenico C.; Signorelli, Diego; Sperduti, Isabella; Cortese, Giada; Risi, Emanuela; Moran, Federica; Sergi, Domenico; Signorelli, Carlo; Natoli, Clara; Ruggeri, Enzo; Zampa, Germano; Russano, Marco; Gamucci, Teresa
Relationship and predictive role of the dual expression of FGFR and IL8 in metastatic renal cell carcinoma (mRCC)	2015	Mosillo, C; Iacovelli, R; DE TURSI, Michele; Ciardi, A; Carella, C; Natoli, Clara; Naso, G; Corstesi, E
Fulvestrant (FUL) 500 milligrams as endocrine therapy (ET) for hormone sensitive advanced breast cancer patients (pts). The Ful500 prospective observational trial	2016	Moscetti, L.; Fabbri, M. A.; Vici, P.; Natoli, Clara; Gamucci, T.; Sperduti, I.; Pizzuti, L.; Iezzi, Laura; Iattoni, E.; Roma, C. L.; Vaccaro, A.; D'Auria, G.; Ruggeri, M. Mauri E. M.
Triple positive early breast cancer in the pre- and post Trastuzumab eras: a subgroup analysis of a multicenter retrospective study.	2014	Pizzuti, L; Natoli, Clara; Gamucci, T; Sergi, D; Di Lauro, L; Moscetti, L; Mentuccia, L; Vaccaro, A.; Trenta, P; Seminara, P; D'Onofrio, L; Rapposelli, ILARIO GIOVANNI; Iezzi, L; Sini, V; Barba, M; Maugeri Sacca, M; Sperduti, I; Marchetti, P; Vici, P
Predictive factors of response to neoadjuvant chemotherapy (NAT) in triple negative breast (TNBC) cancer patients: A restrospective multicenter observational study.	2017	Teresa, Gamucci; Lucia, Mentuccia; Patrizia, Vici; Iezzi, Laura; Isabella, Sperduti; Antonio, Astone; Paolo, Marchetti; Laura, Pizzuti; Andrea, Michelotti; Valentina, Sini; Alessandra, Cassano; Fabrizio, Ciancola; Moscetti, Luca I.; Silvia, Quadrini; Elisabetta, Landucci; Emanuela, Magnolfi; Domenico, Sergi; Natoli, Clara
L’UTILIZZO DEGLI ANTICORPI MONOCLONALI NELLA TERAPIA PER IL MCRC. L’ESPERIENZA DI REAL-LIFE IN UNA ASL ABRUZZESE	2017	Petragnani, N.; Simiele, F.; Antonelli, D.; Zappacosta, I.; Rignanese, L.; Ciampoli, R.; Matera, C.; Laudadio, L.; Natoli, C.; Di Fabio, C.
Impact of BMI on clinical outcome in advanced cancer patients treated with anti‑PD‑1 Immune checkpoint inhibitors: a preliminary analysis	2019	Cortellini, Alessio; DE TURSI, Michele; Tinari, Nicola; Grassadonia, Antonino; Parisi, Alessandro; Iezzi, Laura; Di Marino, Pietro; D’Ostilio, Nicola; Brocco, Davide; Bersanelli, Melissa; Peri, Marta; Cannita, Katia; Ficorella, Corrado; Natoli, Clara
Fulvestrant (FUL) as first-line therapy in HR+ve, HER2-ve advanced breast cancer (ABC) patients (pts): when clinical practice comes earlier than clinical trials. Results from the GIM-13 AMBRA study	2017	Pronzato, P; Mustacch, G; F Riccard, I; A Turletti, I; Michelotti, A; Natoli, C; Livi, L; Del Mastro, L; Donadio, M; Garrone, O; Giordano, M; De Laurentiis, M; Marchett, P; F Montemurro, I; Romagnoli, E; De Placido, S; Biganzoli, L; Cazzaniga, M
Trastuzumab Emtansine (T-DM1) in Patients (pts) With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (MBC): results From a Multicenter Retrospective Analysis	2016	Moscetti, L.; Fabbri, M. A.; Vici, P.; Natoli, Clara; Gamucc, T.; Sperduti, i I.; Pizzuti, L.; Iezzi, Laura; Iatton, E.; Roma, i C. L.; Vaccaro, A.; D'Auria, G.; Ruggeri, M. Mauri E. M.
Choices of first-line therapy in her2-ve advanced breast cancer (abc) patients (pts). prelimary results of the gim-13-ambra study	2016	Cazzaniga, Me; Mustacchi, G; Giordano, M; Garrone, O; Donadio, M; Del Mastro, L; Livi, L; Natoli, Clara; Michelotti, A; Turletti, A; Riccardi, F; Paolo, P; De Placido, S; De Laurentiis, M; Marchetti, P; Montemurro, F
Safety analysis, correlation with response and previous treatments of the association of everolimus (EVE) and exemestane (EXE) in 181 metastatic breast cancer patients (MBC)	2015	Moscetti, L; Vici, P; Sperduti, I; Fabbri, Ma; Natoli, Clara; Mancini, Ml; Sini, V; D'Onofrio, L; Pizzuti, L; Vaccaro, A; Magnolfi, E; Magri, V; Trenta, P; Ramponi, S; Roma, C; Ruggeri, Em
HER2-POSITIVE EARLY BREAST CANCER IN THE PRE-TRASTUZUMAB AND TRASTUZUMAB ERAS: A TRIPLE POSITIVE SUBGROUP ANALYSIS OF A MULTICENTER RETROSPECTIVE STUDY	2014	Pizzuti, Laura; Natoli, Clara; Gamucci, Teresa; Di Lauro, D. Sergi L.; Moscetti, Luca; Mentuccia, Lucia; Vaccaro, Angela; Trenta, P.; Seminara, Patrizia; Rapposelli, I. G.; Sini, V.; Santini, Daniele; Sperduti, Isabella; Marchetti, Paolo; Vici, Patrizia
LGALS3BP, A TUMOR-ASSOCIATED ANTIGEN, UPREGULATES VEGF IN HUMAN BREAST CANCER: POSSIBLE IMPLICATIONS IN ANGIOGENESIS	2008	Cumashi, Albana; Tinari, Nicola; Piccolo, Enza; Rossi, Cosmo; Lattanzio, Rossano; D'Incecco, Arnlida; Grassadonia, Antonino; D'Egidio, Maurizia; Serneraro, Daniela; Piantelli, Mauro; Natoli, Clara; Iacobelli, Stefano

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 201 a 220 di 1.410

Legenda icone

file ad accesso aperto
file disponibili sulla rete interna
file disponibili agli utenti autorizzati
file disponibili solo agli amministratori
file sotto embargo
nessun file disponibile

Scopri

Accesso al fulltext

no fulltext1402
reserved5
open3